Cyclophosphamide "metronomic" chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cyclophosphamide "metronomic" chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer ; volume:7 ; number:1 ; day:15 ; month:4 ; year:2007 ; pages:1-5 ; date:12.2007
BMC cancer ; 7, Heft 1 (15.4.2007), 1-5, 12.2007
- Creator
-
Samaritani, Riccardo
- Contributor
-
Corrado, Giacomo
Vizza, Enrico
Sbiroli, Carlo
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-7-65
- URN
-
urn:nbn:de:1111-2016030344162
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Samaritani, Riccardo
- Corrado, Giacomo
- Vizza, Enrico
- Sbiroli, Carlo
- SpringerLink (Online service)
Other Objects (12)
Chemotherapy for Advanced Epithelial Ovarian Cancer
Intra Peritoneal Chemotherapy in Epithelial Ovarian Cancers
Adjuvant Chemotherapy for Epithelial Ovarian Cancer (EOC)
Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: A Retrospective Study
Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A survival study
Neoadjuvant chemotherapy in epithelial ovarian cancer: Largest single institute experience
Neoadjuvant chemotherapy in epithelial ovarian cancer: Largest single institute experience
Rapidly Progressive Pleuro-parenchymal Fibroelastosis Secondary to Cyclophosphamide Chemotherapy
Cyclophosphamide in Ovarian Cancer Subtypes: Time for a Comeback
Extended adverse effects of cyclophosphamide on mouse ovarian function
Real-life clinical benefit of oral metronomic cyclophosphamide administration in elderly and heavily pretreated epithelial ovarian cancer patients
Palliative chemotherapy: oxymoron or misunderstanding?
Chemotherapy for Advanced Epithelial Ovarian Cancer
Intra Peritoneal Chemotherapy in Epithelial Ovarian Cancers
Adjuvant Chemotherapy for Epithelial Ovarian Cancer (EOC)
Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: A Retrospective Study
Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A survival study
Neoadjuvant chemotherapy in epithelial ovarian cancer: Largest single institute experience
Neoadjuvant chemotherapy in epithelial ovarian cancer: Largest single institute experience
Rapidly Progressive Pleuro-parenchymal Fibroelastosis Secondary to Cyclophosphamide Chemotherapy
Cyclophosphamide in Ovarian Cancer Subtypes: Time for a Comeback
Extended adverse effects of cyclophosphamide on mouse ovarian function
Real-life clinical benefit of oral metronomic cyclophosphamide administration in elderly and heavily pretreated epithelial ovarian cancer patients
Palliative chemotherapy: oxymoron or misunderstanding?
Chemotherapy for Advanced Epithelial Ovarian Cancer
Intra Peritoneal Chemotherapy in Epithelial Ovarian Cancers
Adjuvant Chemotherapy for Epithelial Ovarian Cancer (EOC)
Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: A Retrospective Study
Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A survival study
Neoadjuvant chemotherapy in epithelial ovarian cancer: Largest single institute experience
Neoadjuvant chemotherapy in epithelial ovarian cancer: Largest single institute experience
Rapidly Progressive Pleuro-parenchymal Fibroelastosis Secondary to Cyclophosphamide Chemotherapy
Cyclophosphamide in Ovarian Cancer Subtypes: Time for a Comeback
Extended adverse effects of cyclophosphamide on mouse ovarian function
Real-life clinical benefit of oral metronomic cyclophosphamide administration in elderly and heavily pretreated epithelial ovarian cancer patients